Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

ClinicalTrials.gov ID: NCT00717457

Public ClinicalTrials.gov record NCT00717457. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This 3-arm study will assess the efficacy, safety and tolerability of taspoglutide compared with exenatide in patients with type 2 diabetes mellitus inadequately controlled with metformin, thiazolidinedione or a combination of both. Patients will be randomized to receive taspoglutide (10mg once weekly or 10mg once weekly for 4 weeks followed by 20mg once weekly) or exenatide (5 micrograms twice daily for 4 weeks followed by 10 micrograms twice daily) in a ratio of 1:1:1 in addition to continued prestudy metformin and thiazolidinedione either alone or in combination. The anticipated time on study treatment is 3+ years, and the target sample size is \>500 individuals.

Study identification

NCT ID
NCT00717457
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,189 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2008
Primary completion
Feb 28, 2011
Completion
Feb 28, 2011
Last update posted
Nov 1, 2016

2008 – 2011

United States locations

U.S. sites
87
U.S. states
30
U.S. cities
81
Facility City State ZIP Site status
Not listed Haleyville Alabama 35565
Not listed Mobile Alabama 36617
Not listed Montgomery Alabama 36106
Not listed Tuscaloosa Alabama 35406
Not listed Little Rock Arkansas 72204
Not listed Escondido California 92026
Not listed La Jolla California 92037
Not listed Mission Viejo California 92691
Not listed Orange California 92868
Not listed Palm Springs California 92262
Not listed Rancho Cucamonga California 91730
Not listed Sacramento California 95816-5119
Not listed San Leandro California 94578
Not listed Colorado Springs Colorado 80904
Not listed Daytona Beach Florida 32114
Not listed Fort Lauderdale Florida 33316
Not listed Green Cove Springs Florida 32043
Not listed Jacksonville Florida 32216
Not listed Miami Beach Florida 33140
Not listed Niceville Florida 32578
Not listed Orlando Florida 32804
Not listed Atlanta Georgia 30308
Not listed Atlanta Georgia 30318
Not listed Suwanee Georgia 30024
Not listed Chicago Illinois 60607
Not listed Chicago Illinois 60622
Not listed Lombard Illinois 60148
Not listed Peoria Illinois 61625
Not listed Evansville Indiana 47714
Not listed New Albany Indiana 47150
Not listed Iowa City Iowa 52242
Not listed Munfordville Kentucky 42765
Not listed Metairie Louisiana 70006
Not listed Bangor Maine 04401
Not listed Baltimore Maryland 21209
Not listed Bethesda Maryland 20817
Not listed Rockville Maryland 20854
Not listed Royal Oak Michigan 48073
Not listed Jefferson City Missouri 65109
Not listed Kansas City Missouri 64111
Not listed St Louis Missouri 63117
Not listed St Louis Missouri 63141
Not listed Washington Missouri 63090
Not listed Omaha Nebraska 68114
Not listed Concord New Hampshire 03301
Not listed Trenton New Jersey 08611
Not listed Voorhees Township New Jersey 08043
Not listed Whitehouse New Jersey 08889
Not listed Brooklyn New York 11203
Not listed New York New York 10025
Not listed Rochester New York 14607
Not listed Smithtown New York 11787
Not listed Springfield Gardens New York 11413
Not listed Staten Island New York 10301
Not listed Syracuse New York 13210
Not listed West Seneca New York 14224
Not listed Westfield New York 14787
Not listed Charlotte North Carolina 28209
Not listed Charlotte North Carolina 28233
Not listed Durham North Carolina 27713
Not listed Greensboro North Carolina 27408
Not listed Huntersville North Carolina 28078
Not listed Salisbury North Carolina 28144
Not listed Winston-Salem North Carolina 27103
Not listed Fargo North Dakota 58103
Not listed Cincinnati Ohio 45236
Not listed Columbus Ohio 43212
Not listed Westlake Ohio 44145
Not listed Medford Oregon 97504
Not listed Portland Oregon 97239
Not listed Altoona Pennsylvania 16602
Not listed Norristown Pennsylvania 19401
Not listed Philadelphia Pennsylvania 19107
Not listed Red Lion Pennsylvania 17356
Not listed Providence Rhode Island 02908
Not listed Clemson South Carolina 29631
Not listed Columbia South Carolina 29201
Not listed Hickory Grove South Carolina 28602
Not listed Simpsonville South Carolina 29681
Not listed Bristol Tennessee 37620
Not listed Austin Texas 78705
Not listed Dallas Texas 75230
Not listed Houston Texas 77005
Not listed Houston Texas 77024
Not listed Houston Texas 77074
Not listed Richmond Virginia 23226
Not listed Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 129 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00717457, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2016 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00717457 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →